Comparison of hand-placed spiral nasojejunal tube and endoscopic-placed transendoscopic enteral tube in the treatment of fecal microbiota transplantation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025057

Enrollment

Unknown

Registered

2019-08-09

Start date

2019-08-15

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A disease of the digestive system requiring fecal microbiota transplantation by the way of mid-gut

Interventions

spiral nasojejunal tube group:hand-placed spiral nasojejunal tube

transendoscopic enteral tube group :endoscopic-placed transendoscopic enteral tube

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who needed FMT treatment for digestive system disease agreed to choose the mid-gut catheterization. 2. Age: 18-80. 3. Catheterization time is more than 2 days. 4. During the catheterization, the patient can cooperate with the treatment and does not take the initiative to extubate.

Exclusion criteria

Exclusion criteria: 1. Esophageal stricture, nasopharyngeal tumors 2. Contraindication for gastroscopy (e.g., patients with severe cardiopulmonary and brain diseases, patients with mental disorders that cannot cooperate, patients with extreme failure that cannot tolerate gastroscopy, etc.) 3. Withdrawal from the study was required during follow-up. 4. Inability to cooperate with the interviewer.

Design outcomes

Primary

Measure	Time frame
comfort level;complication;economic cost;	—

Countries

China

Contacts

Public ContactLihao Wu

The First Affiliated Hospital of Guangdong Pharmaceutical University

wulihao888@126.com+86 020 61321457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026